XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss).
Non-Controlling Interest
Total
Balance at beginning of period at Dec. 31, 2021 $ 345 $ 60,628 $ (251,725) $ 12,018 $ 2,736 $ (175,998)
Balance at beginning of period (in shares) at Dec. 31, 2021 34,523          
Net income (loss)     (23,585)   43 (23,542)
Issuance of common shares upon closing of de-SPAC merger transaction, net of issuance costs, net of $2,469 of taxes (see Note 4) $ 129 805       934
Issuance of common shares upon closing of de-SPAC merger transaction, net of issuance costs, net of $2,469 of taxes (see Note 4) (in shares) 12,868          
Issuance of common shares related to PIPE financing $ 206 205,694       205,900
Issuance of common shares related to PIPE financing (in shares) 20,590          
Issuance of common shares related to conversion of debt to equity (see Note 12) $ 25 24,975       25,000
Issuance of common shares related to conversion of debt to equity (see Note 12) (in shares) 2,500          
Issuance of common shares related to conversion of Common Equivalent Preferred Units (see Note 4) $ 22 23,731       23,753
Issuance of common shares related to conversion of Common Equivalent Preferred Units (see Note 4) (in shares) 2,220          
Common Equivalent Preferred Unit dividends ($0.02 per unit)     (4,380)     (4,380)
Loss on extinguishment of Common Equivalent Preferred units     (2,870)     (2,870)
Other comprehensive income (loss)       (10,095)   (10,095)
Equity-based compensation $ 3 1,181       1,184
Equity-based compensation (in shares) 333          
Net share settlement of equity awards   (477)       (477)
Accumulating preferred dividends     (13,882)     (13,882)
Balance at end of period at Sep. 30, 2022 $ 730 316,537 (296,442) 1,923 2,779 25,527
Balance at end of period (in shares) at Sep. 30, 2022 73,034          
Balance at beginning of period at Jun. 30, 2022 $ 348 60,627 (276,196) 4,724 2,801 (207,696)
Balance at beginning of period (in shares) at Jun. 30, 2022 34,856          
Net income (loss)     (12,996)   (22) (13,018)
Issuance of common shares upon closing of de-SPAC merger transaction, net of issuance costs, net of $2,469 of taxes (see Note 4) $ 129 805       934
Issuance of common shares upon closing of de-SPAC merger transaction, net of issuance costs, net of $2,469 of taxes (see Note 4) (in shares) 12,868          
Issuance of common shares related to PIPE financing $ 206 205,694       205,900
Issuance of common shares related to PIPE financing (in shares) 20,590          
Issuance of common shares related to conversion of debt to equity (see Note 12) $ 25 24,975       25,000
Issuance of common shares related to conversion of debt to equity (see Note 12) (in shares) 2,500          
Issuance of common shares related to conversion of Common Equivalent Preferred Units (see Note 4) $ 22 23,731       23,753
Issuance of common shares related to conversion of Common Equivalent Preferred Units (see Note 4) (in shares) 2,220          
Common Equivalent Preferred Unit dividends ($0.02 per unit)     (4,380)     (4,380)
Loss on extinguishment of Common Equivalent Preferred units     (2,870)     (2,870)
Other comprehensive income (loss)       (2,801)   (2,801)
Equity-based compensation   705       705
Balance at end of period at Sep. 30, 2022 $ 730 316,537 (296,442) 1,923 2,779 25,527
Balance at end of period (in shares) at Sep. 30, 2022 73,034          
Balance at beginning of period at Dec. 31, 2022 $ 750 342,664 (328,042) (6,103) 2,460 11,729
Balance at beginning of period (in shares) at Dec. 31, 2022 75,020          
Net income (loss)     (14,531)   15 (14,516)
Issuance of common shares related to conversion of Common Equivalent Preferred Units (see Note 4) $ 119 117,648       117,767
Issuance of common shares related to conversion of Common Equivalent Preferred Units (see Note 4) (in shares) 11,877          
Issuance of common shares related to acquisitions   446       446
Issuance of common shares related to acquisitions (in shares) 40          
Issuance of common shares related to Public Warrant exercise $ 2 3,142       3,144
Issuance of common shares related to Public Warrant exercise (in shares) 229          
Issuance of common shares related to stock options exercised $ 1 847       848
Issuance of common shares related to stock options exercised (in shares) 88          
Issuance of common shares related to conversion of Series A Convertible Preferred Shares $ 1 881       882
Issuance of common shares related to conversion of Series A Convertible Preferred Shares (in shares) 76          
Issuance of common shares related to purchase of non-controlling interest $ 1 474       (2,000)
Issuance of common shares related to purchase of non-controlling interest (in shares) 100          
Issuance of common shares related to purchase of non-controlling interest         $ (2,475)  
Accretion of Series A Convertible Preferred Shares   (249)       (249)
Other comprehensive income (loss)       4,806   4,806
Equity-based compensation $ 6 6,291       6,297
Equity-based compensation (in shares) 609          
Net share settlement of equity awards   (2,977)       (2,977)
Balance at end of period at Sep. 30, 2023 $ 880 469,167 (342,573) (1,297)   126,177
Balance at end of period (in shares) at Sep. 30, 2023 88,039          
Balance at beginning of period at Jun. 30, 2023 $ 757 348,714 (359,194) (4,539)   (14,262)
Balance at beginning of period (in shares) at Jun. 30, 2023 75,728          
Net income (loss)     16,621     16,621
Issuance of common shares related to conversion of Common Equivalent Preferred Units (see Note 4) $ 119 117,648       117,767
Issuance of common shares related to conversion of Common Equivalent Preferred Units (see Note 4) (in shares) 11,877          
Issuance of common shares related to stock options exercised $ 1 785       786
Issuance of common shares related to stock options exercised (in shares) 82          
Issuance of common shares related to conversion of Series A Convertible Preferred Shares   627       627
Issuance of common shares related to conversion of Series A Convertible Preferred Shares (in shares) 54          
Accretion of Series A Convertible Preferred Shares   93       93
Other comprehensive income (loss)       3,242   3,242
Equity-based compensation $ 3 2,436       2,439
Equity-based compensation (in shares) 298          
Net share settlement of equity awards   (1,136)       (1,136)
Balance at end of period at Sep. 30, 2023 $ 880 $ 469,167 $ (342,573) $ (1,297)   $ 126,177
Balance at end of period (in shares) at Sep. 30, 2023 88,039